The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy

BACKGROUND: The impact of cumulative dose of cisplatin on clinical outcomes of nasopharyngeal carcinoma (NPC) patients who received intensity-modulated radiotherapy (IMRT) was evaluated. METHODS: This study included 491 consecutive patients with histologically confirmed NPC who were treated with con...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Shan-Shan, Tang, Lin-Quan, Zhang, Lu, Chen, Qiu-Yan, Liu, Li-Ting, Guo, Ling, Mo, Hao-Yuan, Luo, Dong-Hua, Huang, Pei-Yu, Xiang, Yan-Qun, Sun, Rui, Chen, Ming-Yuan, Wang, Lin, Lv, Xing, Zhao, Chong, Guo, Xiang, Cao, Ka-Jia, Qian, Chao-Nan, Zeng, Mu-Sheng, Bei, Jin-Xin, Hong, Ming-Huang, Shao, Jian-Yong, Sun, Ying, Ma, Jun, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682221/
https://www.ncbi.nlm.nih.gov/pubmed/26675209
http://dx.doi.org/10.1186/s12885-015-1964-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682221/
https://www.ncbi.nlm.nih.gov/pubmed/26675209
http://dx.doi.org/10.1186/s12885-015-1964-8

Ejemplares similares